Abstract:BRCA 1/2 genes mutation status can already determine the therapeutic algorithm of high grade serous ovarian cancer patients. Nevertheless, its assessment is not sufficient to identify all patients with genomic instability, since BRCA 1/2 mutations are only the most well-known mechanisms of homologous recombination deficiency (HR-d) pathway, and patients displaying HR-d behave similarly to BRCA mutated patients. HRd assessment can be challenging and is progressively overcoming BRCA testing not only for prognostic information but more importantly for drugs prescriptions. However, HR testing is not already integrated in clinical practice, it is quite expensive and it is not refundable in many countries. Selecting patients who are more likely to benefit from this assessment (BRCA 1/2 WT patients) at an early stage of the diagnostic process, would allow an optimization of genomic profiling resources. In this study, we sought to explore whether somatic BRCA1/2 genes status can be predicted using computational pathology from standard hematoxylin and eosin histology. In detail, we adopted a publicly available, deep-learning-based weakly supervised method that uses attention-based learning to automatically identify sub regions of high diagnostic value to accurately classify the whole slide (CLAM). The same model was also tested for progression free survival (PFS) prediction. The model was tested on a cohort of 664 (training set: n = 464, testing set: n = 132) ovarian cancer patients, of whom 233 (35.1%) had a somatic BRCA 1/2 mutation. An area under the curve of 0.7 and 0.55 was achieved in the training and testing set respectively. The model was then further refined by manually identifying areas of interest in half of the cases. 198 images were used for training (126/72) and 87 images for validation (55/32). The model reached a zero classification error on the training set, but the performance was 0.59 in terms of validation ROC AUC, with a 0.57 validation accuracy. Finally, when applied to predict PFS, the model achieved an AUC of 0.71, with a negative predictive value of 0.69, and a positive predictive value of 0.75. Based on these analyses, we have planned further steps of development such as proving a reference classification performance, exploring the hyperparameters space for training optimization, eventually tweaking the learning algorithms and the neural networks architecture for better suiting this specific task. These actions may allow the model to improve performances for all the considered outcomes.

Deep Interactive Learning-based ovarian cancer segmentation of H&E-stained whole slide images to study morphological patterns of BRCA mutation

Automated Ovarian Cancer Identification Using End-to-End Deep Learning and Second Harmonic Generation Imaging

Deep Learning for Detecting BRCA Mutations in High-Grade Ovarian Cancer Based on an Innovative Tumor Segmentation Method From Whole Slide Images

Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer

Deep Learning-Based Semantic Segmentation of Non-Melanocytic Skin Tumors in Whole-Slide Histopathological Images.

Prediction of BRCA Gene Mutation in Breast Cancer Based on Deep Learning and Histopathology Images

Deep Learning-Based Cancer Region Segmentation from H&E Slides for HPV-Related Oropharyngeal Squamous Cell Carcinomas

Deep learning-based segmentation of multisite disease in ovarian cancer

Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent

DeepSDCS: Dissecting cancer proliferation heterogeneity in Ki67 digital whole slide images

Computer-aided Detection of Squamous Carcinoma of the Cervix in Whole Slide Images

Deep Learning for Survival Analysis in Breast Cancer with Whole Slide Image Data

Deep learning for multi-class semantic segmentation enables colorectal cancer detection and classification in digital pathology images

Automated segmentation of cell membranes to evaluate HER2 status in whole slide images using a modified deep learning network

Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer

Breast Tumor Tissue Segmentation with Area-Based Annotation Using Convolutional Neural Network

Deep learning-based instance segmentation for the precise automated quantification of digital breast cancer immunohistochemistry images

3D Breast Cancer Segmentation in DCE-MRI Using Deep Learning With Weak Annotation

Breast MRI Segmentation and Ki-67 High- and Low-Expression Prediction Algorithm Based on Deep Learning

A Deep Learning Approach for Histology-Based Nucleus Segmentation and Tumor Microenvironment Characterization

Learning from Thresholds: Fully Automated Classification of Tumor Infiltrating Lymphocytes for Multiple Cancer Types